Moderna faces PMCPA audit over ‘completely unacceptable’ lack of transparency
Moderna is being audited by the PMCPA after once again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from the U.K. trade group ABPI. The latest case identified a “completely unacceptable” lack of transparency by Moderna.
Moderna is being audited by the PMCPA after once again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from the U.K. trade group ABPI. The latest case identified a “completely unacceptable” lack of transparency by Moderna.
